tiprankstipranks
Passage Bio (PASG)
NASDAQ:PASG
US Market

Passage Bio (PASG) Financial Statements

407 Followers

Passage Bio Financial Overview

Passage Bio's market cap is currently ―. The company's EPS TTM is $-1.532; its P/E ratio is -0.61; Passage Bio is scheduled to report earnings on August 1, 2024, and the estimated EPS forecast is $-0.31. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -16.75M$ -16.76M$ -27.12M$ -23.86M$ -34.34M
EBITDA$ -16.39M$ -16.76M$ -26.54M$ -23.63M$ -33.44M
Net Income Common Stockholders$ -16.71M$ -16.76M$ -27.12M$ -23.86M$ -34.34M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 104.53M$ 114.29M$ 132.78M$ 151.48M$ 167.77M
Total Assets$ 140.53M$ 150.54M$ 169.26M$ 193.70M$ 213.24M
Total Debt$ 26.48M$ 26.29M$ 26.52M$ 26.74M$ 26.95M
Net Debt$ -78.05M$ -88.00M$ -106.26M$ -124.74M$ -140.82M
Total Liabilities$ 35.65M$ 39.26M$ 42.98M$ 43.28M$ 42.89M
Stockholders Equity$ 104.88M$ 111.28M$ 126.28M$ 150.41M$ 170.35M
Cash Flow-
Free Cash Flow$ -18.93M$ -19.53M$ -19.17M$ -17.18M$ -22.45M
Operating Cash Flow$ -18.93M$ -19.52M$ -19.16M$ -17.08M$ -22.42M
Investing Cash Flow$ 25.25M$ 7.60M$ 22.45M$ 13.97M$ 21.22M
Financing Cash Flow$ 8.74M$ 46.00K-$ 89.00K-
Currency in USD

Passage Bio Earnings and Revenue History

Passage Bio Debt to Assets

Passage Bio Cash Flow

Passage Bio Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis